Comorbidities associated with vitiligo: a ten-year retrospective study.

Area of Science:

• Dermatology
• Autoimmunology
• Epidemiology

Background:

• Vitiligo, a depigmentation disorder, is often linked to other autoimmune diseases.
• There is a lack of recent, large-scale data on vitiligo comorbidities in the US population.

Purpose of the Study:

• To determine the prevalence of comorbidities in vitiligo patients.
• To identify associated laboratory abnormalities in individuals with vitiligo.

Main Methods:

• Retrospective analysis of medical records (2000-2011) for 2,441 vitiligo patients using an AI-based program.
• Validation of vitiligo diagnosis through manual record review for a subset of patients.
• Identification of comorbid autoimmune conditions and collection of laboratory data.

Main Results:

• 23% of vitiligo patients had comorbid autoimmune conditions, with thyroid disorders (287) and psoriasis (186) being most common.
• Elevated anti-nuclear antibody levels were found in 41% of patients.
• Over 50% of patients had low or insufficient vitamin D levels, and nearly half had elevated thyroid peroxidase antibodies.

Conclusions:

• A high prevalence of comorbidities, especially autoimmune conditions like thyroid disorders and psoriasis, was observed in vitiligo patients.
• Screening for comorbidities, particularly thyroid disorders, is advisable for vitiligo patients.
• Findings highlight the significant association between vitiligo and other autoimmune conditions.